Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Perseus Proteomics Inc.
No Price
Closing Price XTKS 28.04.2026:
218,00 JPY
28.04.2026 06:30
Current Prices from Perseus Proteomics Inc.
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
Tokyo
4882.T
JPY
28.04.2026 06:30
218,00 JPY
-
Share Float & Liquidity
Free Float97,37 %
Shares Float14,36 M
Shares Outstanding14,75 M
Company Profile for Perseus Proteomics Inc. Share
Perseus Proteomics Inc., a drug discovery biotech venture company, develops antibody drugs against cancer and other diseases in Japan. The company is involved in the antibody discovery activities; and antibody research support activities comprising hybridoma antibody sequencing, antibody protein production, and contract antibody research activities, as well as supply of antibody products. Its product pipeline includes PPMX-T001, an anti-hepatocarcinoma antibody; PPMX-T002, an anticancer drug; PPMX-T003, a drug for the treatment of adult T-cell; and PPMX-T004, an antibody drug conjugate. The company was incorporated in 2001 and is headquartered in Tokyo, Japan.
